Head and neck cancer: Overview of recent developments and future directions

Seminars in Oncology

Volumn 27, Issue 4, 2000, Pages 1-4

  Forastiere, A A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DEATH; HEAD CANCER; HUMAN; LARYNX CANCER; META ANALYSIS; METASTASIS; NASOPHARYNX CARCINOMA; NECK CANCER; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUMOR REGRESSION;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MEDICAL ONCOLOGY;

EID: 0033898259     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
3. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
4. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
5. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group
6. A meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (2) Larynx preservation using neoadjuvant chemotherapy (CT) in laryngeal and hypopharyngeal carcinoma
7. National Comprehensive Cancer Network practice guidelines for head and neck cancer
8. Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network practice guidelines
9. Precisely defining high-risk operable head and neck tumors based on RTOG 85-03 and 88-24: Targets for postoperative radiochemotherapy?
10. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034
11. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial
12. Concurrent chemoradiation in the treatment of head and neck cancer
13. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
14. Radiation therapy versus concomitant chemoradiotherapy for stages III/IV oropharynx cancer. A GORTEC randomized trial
15. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
16. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
17. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
18. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy (RT) alone in resectable stage III and IV squamous cell head and neck cancer (SCHNC)
19. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003
20. Altered fractionation trials in head and neck cancer
21. Radiotherapy and concurrent chemotherapy: A strategy that improves locoregional control and survival in oropharyngeal cancer
22. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
23. Chemotherapy in head and neck cancer